ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $341,000 | +218.7% | 28,959 | +327.1% | 0.00% | +100.0% |
| Q2 2018 | $107,000 | -18.9% | 6,781 | -41.3% | 0.00% | 0.0% |
| Q4 2017 | $132,000 | -25.8% | 11,561 | -25.8% | 0.00% | -50.0% |
| Q2 2017 | $178,000 | +14.8% | 15,580 | +109.4% | 0.00% | +100.0% |
| Q1 2017 | $155,000 | -65.8% | 7,440 | -65.8% | 0.00% | -75.0% |
| Q4 2016 | $453,000 | +327.4% | 21,763 | +570.2% | 0.00% | +300.0% |
| Q3 2016 | $106,000 | -40.8% | 3,247 | -55.7% | 0.00% | 0.0% |
| Q1 2016 | $179,000 | -26.9% | 7,323 | -2.1% | 0.00% | 0.0% |
| Q3 2015 | $245,000 | +99.2% | 7,481 | +75.8% | 0.00% | 0.0% |
| Q1 2015 | $123,000 | -3.1% | 4,255 | -2.8% | 0.00% | 0.0% |
| Q4 2014 | $127,000 | – | 4,379 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |